2022 TriNetX Summit Recording – Addressing Research Challenges with Diversity and Inclusion
Hear about reducing bias, promoting social equity, and producing innovative science informed by a representative population.
Overview
Diversity is a moral and scientific issue in clinical research. Hear members of the TriNetX community discuss the importance and efforts undertaken to reduce bias, promote social equity and empowerment, and produce innovative science informed by a representative population of patients that will ultimately receive treatment.
Speakers
Josh Hartman
Director, Clinical Feasibility and Analytics, TriNetX, LLC
Bill Adams, MD
Professor of Pediatrics, Boston University School of Medicine
Laura Doremus
Global Health Insights Associate Director, D&I, Novartis
Vesna Rysdale
Global Strategic Feasibility, PPD
Janel Titus
Real-World Data Engagement Lead, Takeda